Case 1:07-cv-00331-SLR
Document 18
Filed 07/25/2007
Page 1 of 1
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 1 of 9
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TAKEDA PHARMACEUTICAL COMPANY LIMITED, a Japanese Corporation, TAP PHARMACEUTICAL PRODUCTS INC., a Delaware Corporation, and ETHYPHARM, S.A., a French Corporation, Plaintiffs, v. TEVA PHARMACEUTICALS USA, INC. a Delaware Corporation, and TEVA PHARMACEUTICAL INDUSTRIES LTD., an Israeli Corporation, Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
C.A. No. 07-331-SLR
ORDER At Wilmington this ___ day of July 2007, the parties having satisfied their obligations under Fed. R. Civ. P. 26(f), and the court having conducted a pretrial scheduling conference pursuant to Fed. R. Civ. P. 16 and D. Del. LR 16.1(a) and (b). IT IS ORDERED that: 1. Pre-Discovery Disclosures. The parties will exchange by August 7, 2007,
the information required by Fed. R. Civ. P. 26(a)(1) and D. Del. LR 16.1. 2. Discovery. (a) Discovery will be needed on the following subjects: (1) (2) (3) Infringement or non-infringement of the patents-in-suit; Validity or invalidity of the patents-in-suit; Any other claims, counterclaims, and/or defenses; and
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 2 of 9
(4)
Discovery also may be needed for additional subjects for
other claims, counterclaims, or defenses to the extent that they may be asserted during discovery. (b) [PLAINTIFFS: No discovery is required in this case with respect to
the validity or enforceability of U.S. Patent Nos. 4,628,098 and 5,045,321, which are the subject of pending litigation in this Court, C.A. No. 06-33-SLR ("the `06 Action"). Any final, non-appealable judgment with respect to the validity and/or enforceability of U.S. Patent Nos. 4,628,098 and/or 5,045,321 in the '06 Action shall be binding upon the parties in this case.] [DEFENDANTS: No discovery is required in this case on issues strictly related to the validity of U.S. Patent Nos. 4,628,098 and 5,045,321 ("the `06 Action"). Any final, non-appealable judgment with respect to the validity of U.S. Patent Nos. 4,628,098 and/or 5,045,321 in the `06 Action shall be binding upon the parties in this case. Any final, non-appealable judgment with respect to the infringement or noninfringement of U.S. Patent No. 4,628,098 shall be binding upon the parties in this case.] (c) All fact discovery shall be commenced in time to be completed by
[PLAINTIFFS: October 3, 2008; DEFENDANTS: February 25, 2008]. (1) Document production shall be completed on or before
[PLAINTIFFS: March 3, 2008; DEFENDANTS: October 25, 2007]. (2) party to any other party. (3) In the absence of agreement among the parties, contention Maximum of 25 interrogatories including subparts by each
interrogatories, if filed, shall first be addressed by the party with the burden of proof no later than the date established for the completion of document production, with the responsive answers due
2
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 3 of 9
within thirty (30) days thereof. The adequacy of all such interrogatory answers shall be judged by the level of detail each party provides; i.e., the more detail a party provides, the more detail a party shall receive. (4) any other party. (5) In the absence of agreement among the parties or by order Maximum of 50 requests for admission by each party to
of the court, no deposition (other than those noticed under Fed. R. Civ. P. 30(b)(6)) shall be scheduled prior to the completion of document production. (6) Maximum of 120 hours per side for fact depositions. Each
fact deposition (other than depositions requiring translation) is limited to a maximum of 7 hours per deposition, unless extended by agreement of parties. Depositions that require translation are limited to a maximum of 14 hours, unless extended by agreement of parties. (d) Expert discovery shall be commenced after the completion of fact
discovery and in time to be completed by [PLAINTIFFS: June 14, 2009; DEFENDANTS: May 23, 2008]. (1) Expert reports on issues for which the parties have the
burden of proof are due [PLAINTIFFS: April 6, 2009; DEFENDANTS: March 25, 2008]. Rebuttal expert reports are due [PLAINTIFFS: May 4, 2009; DEFENDANTS: April 25, 2008]. (2) Expert depositions to be limited to a maximum of 7 hours
per expert unless extended by agreement of the parties. (3) close of expert discovery. All Daubert motions shall be filed within 30 days after the
3
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 4 of 9
(e)
If Defendants intend to rely on advice of counsel for any purpose,
including without limitation as a defense to willfulness, exceptional case, or inducement, Defendants must so inform Plaintiffs by January 14, 2008. If the decision is to rely on such advice, the scope of discovery shall include the materials provided by Defendant to its counsel and whatever other materials related to the issues in dispute that Defendant had in its possession at the time the advice was sought. (f) (g) Supplementations under Rule 26(e) are due as required by that rule. Discovery Disputes. (1) The court shall conduct an in-person discovery status
conference on [PLAINTIFFS: January 14, 2008 at __ a.m./p.m.; DEFENDANTS: December 14, 2007 (after document production is completed on October 25, 2007)], the time to be allocated equally among the parties. No motions to compel or motions for protective order shall be filed absent approval of the court. (2) The court shall remain available to resolve by telephone
conference disputes that arise during the course of a deposition and disputes over the terms of a protective order. (3) Absent express approval of the court following a discovery
conference, no motions pursuant to Fed. R. Civ. P. 37 shall be filed. (h) Fact Witnesses to be Called at Trial. Within one (1) month
following the close of expert discovery, each party shall serve on the other parties a list of each fact witness (including any expert witness who is also expected to give fact testimony), who has previously been disclosed during discovery and that it intends to call at trial. Within one (1) month of receipt of such fact witness list, each party shall serve a list of each rebuttal fact
4
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 5 of 9
witness that it intends to call at trial. The parties shall have the right to depose any such fact witnesses who have not previously been deposed in this case. Such deposition shall be held within one (1) month after service of the list of rebuttal fact witnesses and shall be limited to twenty (20) hours per side in the aggregate unless extended by agreement of the parties or upon order of the court upon good cause shown. 3. Joinder of other Parties and Amendment of Pleadings. All motions to
join other parties and amend the pleadings shall be filed on or before [PLAINTIFFS: April 14, 2008; DEFENDANTS: October 25, 2007]. 4. Settlement Conference. Pursuant to 28 U.S.C. ยง 636 and to the extent
the parties believe it may be beneficial, this matter is referred to a Magistrate Judge for the purposes of exploring ADR. 5. Claim Construction Issue Identification. If the court does not find that
a limited earlier claim construction would be helpful in resolving the case, the parties shall exchange lists of those claim terms that they believe need construction and their proposed claim construction of those terms on [PLAINTIFFS: May 18, 2009; DEFENDANTS: March 31, 2008]. This document will not be filed with the court. Subsequent to exchanging such lists, the parties will meet and confer to prepare a Joint Claim Construction Statement to be submitted pursuant to paragraph 6 below. [DEFENDANTS: Defendants respectfully request that the Court hold a Markman Hearing prior to the close of fact discovery, and that expert discovery not commence until the Court issues its claim construction order. This proposed change in the schedule would allow the parties' expert witnesses to opine on the infringement and validity of the patent claims as construed by the Court. If the Court is
5
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 6 of 9
amenable to this proposed change in schedule, the parties will submit a new proposed schedule based on this order of events.] 6. Claim Construction. Lawyers must identify, during the claim
construction phase of the case, any claim language that will have a meaning to a person of ordinary skill in the art that differs from the ordinary meaning. Any language not so identified will be construed according to its ordinary meaning. The parties shall agree upon and file the Joint Claim Construction Statement contemporaneous with the Pretrial Order, with the claim chart separately docketed. The parties will file simultaneous opening claim construction briefs on [PLAINTIFFS: June 15, 2009; DEFENDANTS: June 25, 2008]. Simultaneous response briefs should be filed by
[PLAINTIFFS: July 20, 2009; DEFENDANTS: July 25, 2008]. Issues of claim construction shall be considered by the court in conjunction with trial. 7. Applications by Motion. Any application to the court shall be by written
motion filed with the clerk. The court will not consider applications and requests submitted by letter or in a form other than a motion, absent express approval by the court. (a) Any non-dispositive motion should contain the statement
required by D. Del. LR 7.1.1. (b) (c) No telephone calls shall be made to chambers. Any party with an emergency matter requiring the assistance of
the court shall e-mail chambers utilizing the "E-mail Request for Emergency Relief" and "Opposing Counsel's Response" forms posted on Chief Judge Robinson's website and e-mail the completed forms to [email protected]. The e-mail shall provide a short statement
6
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 7 of 9
describing the emergency. NO ATTACHMENTS shall be submitted in connection with said emails. 8. Motions in Limine. No motions in limine shall be filed; instead the
parties shall be prepared to address their evidentiary issues at the pretrial conference and during trial (before and after the trial day). 9. Pretrial Conference. A pretrial conference will be held on
[PLAINTIFFS: July 29, 2009 at __ p.m./a.m.; DEFENDANTS: September 8, 2008 at ___ a.m./p.m.] in courtroom 6B, sixth floor Federal Building, 844 King Street, Wilmington, Delaware. The Federal Rules of Civil Procedure and D. Del. LR 16.3 shall govern the pretrial conference. 10. Trial. This matter is scheduled for a two-week bench trial commencing
on [PLAINTIFFS: September 7, 2009; DEFENDANTS: September 22, 2008] in courtroom 6B, sixth floor Federal Building, 844 King Street, Wilmington, Delaware. For purposes of completing pretrial preparations, the parties should plan on being allocated a total number of hours in which to present their respective cases.
United States District Judge
7
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 8 of 9
ADDITIONAL PROVISIONS TO SCHEDULING ORDER 1. DISCOVERY: The parties agree that attorney-work product and attorney-
client privileged materials created by counsel after the service of the Paragraph IV Certification letter for ANDA No. 77-255 by Teva on TAP Pharmaceutical Products Inc. are to be excluded from production and need not be placed on any privilege logs produced in response to any discovery requests with the exception of updates provided to the FDA, communications with the PTO concerning the patents-in-suit, and any communications with any court or any opposing party in a civil action regarding the patents-in-suit. 2. The parties agree that if a witness intends to testify in a language other
than English at a deposition or otherwise requires a translator, the party defending the witness will provide the noticing party timely notice in advance of the deposition. Further, to the extent a witness testifies at deposition in a foreign language, that witness will also testify in that language at trial. 3. The parties agree to make reasonable efforts to schedule depositions on
mutually convenient dates and locations for counsel and witnesses. Each party agrees to make available for deposition any testifying expert witness at a mutually agreeable location in the United States. In the absence of an agreement otherwise, Plaintiffs will make their testifying expert witnesses available for deposition at the New York, NY office of Plaintiffs' counsel, and Defendants will make their testifying expert witnesses available for deposition at the Atlanta, GA office of Defendants' counsel. 4. PROTECTIVE ORDER: The parties agree that a Protective Order is
necessary and appropriate to govern pre-trial matters in the case. The parties are amenable to
8
Case 1:07-cv-00331-SLR
Document 18-2
Filed 07/25/2007
Page 9 of 9
preparing a mutually agreeable protective order and will file a motion for entry of protective order as soon as practicable. 5. SERVICE: The parties agree to serve papers on each other by emailing a
pdf to all Counsel of Record, excluding large appendices, and by depositing all documents with an overnight courier on or before the date when such papers are due or are filed with the Court. Service by overnight courier to Plaintiffs shall be made on Arlene L. Chow at Hogan & Hartson in New York and Stuart E. Pollack at Patterson Belknap Webb & Tyler in New York, and service by overnight courier to Defendants shall be made on Laura F. Fritts at Sutherland Asbill & Brennan in Atlanta, Georgia. All documents shall be concurrently served on each party's local counsel by the same means. Service by emailing a pdf shall be considered service by hand delivery for purposes of FRCP 6(e) if the email of the pdf(s) contains the complete document, including appendices or other attachments. The parties also agree that documents and things produced pursuant to Rules 26 & 34 of the Federal Rules of Civil Procedure need not be served in accordance with the earlier provisions of this paragraph and may be provided to the receiving party in accordance with the terms of those Rules or by any other means mutually agreed upon by the parties hereto. 6. CROSS-DESIGNATION STIPULATION: The parties agree to be bound
by a Cross-Designation Stipulation that allows all discovery provided by and exchanged between Takeda, TAP, Teva USA and Teva Ltd. in the `06 Action to be treated as having been produced by the same party and made available for use by the Parties in the current litigation.
9